News
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...
Generally, fighting cancer is about delivering a relentless attack on the spreading disease, but a new approach explores the ...
ALLO-316 shows promising results in advanced renal cell carcinoma, with a 25% response rate and rapid treatment turnaround, ...
Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, ...
In the realm of cancer biology, the intersection of aging and cancer presents unique challenges, characterized by tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results